Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan

被引:67
作者
Sheu, JC
Lin, YW
Chou, HC
Huang, GT
Lee, HS
Lin, YH
Huang, SY
Chen, CH
Wang, JT
Lee, PH
Lin, JT
Lu, FJ
Chen, DS
机构
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Coll Med, Taipei 100, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Surg, Coll Med, Taipei 100, Taiwan
[3] Natl Taiwan Univ, Dept Biochem, Taipei 10764, Taiwan
关键词
loss of heterozygosity; microsatellite; hepatocellular carcinoma;
D O I
10.1038/sj.bjc.6690380
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Elucidation of the basic genetic changes of human hepatocellular carcinoma is important for the understanding and treatment of this cancer. We used microsatellite polymorphism markers to study 30 cases of hepatocellular carcinoma (34 tumours) on all human chromosomes. DNA from 34 pairs of hepatocellular carcinomas and corresponding non-tumour parts was prepared. Loss of heterozygosity (LOH) and microsatellite instability on 23 chromosomes were investigated by 231 sets of microsatellite markers. More than 20% LOH was shown for loci on 16q (47.1%), 13q (32.4%), 17p (32.4%), 50 (26.5%), 11p (23.5%) and 9p (20.6%). the commonly affected regions were mapped to 16q12.1, 16q12.2, 16q24, 13q12.1-32, 17p13, 5q32, 5q34, 5q3, 11p15, 11q23-24 and 9p21. Hepatitis B virus carriers had a significantly higher frequency of LOH on chromosomes 5q, 11p and 16q. Furthermore, larger tumour size tended to have higher frequency of LOH at D16S409 locus (16q12.1). Microsatellite instability was only found in 12 of 231 markers and the frequency is very low. These data suggest that the chromosomes 16q, 13q, 17p, 5q, 11p and 9p might participate in hepatocarcinogenesis. However, microsatellite instability might play little role in the development of this cancer in Taiwan.
引用
收藏
页码:468 / 476
页数:9
相关论文
共 52 条
[1]  
BEASLEY RP, 1982, HEPATOLOGY S, V2, P21
[2]  
Becker SA, 1996, CANCER RES, V56, P5092
[3]   LOSS OF HETEROZYGOSITY SUGGESTS TUMOR SUPPRESSOR GENE RESPONSIBLE FOR PRIMARY HEPATOCELLULAR-CARCINOMA [J].
BUETOW, KH ;
MURRAY, JC ;
ISRAEL, JL ;
LONDON, WT ;
SMITH, M ;
KEW, M ;
BLANQUET, V ;
BRECHOT, C ;
REDEKER, A ;
GOVINDARAJAH, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8852-8856
[4]  
Chen D-S, 1987, NEOPLASMS LIVER, P71
[5]   HEPATITIS-C VIRUS-INFECTION IN AN AREA HYPERENDEMIC FOR HEPATITIS-B AND CHRONIC LIVER-DISEASE - THE TAIWAN EXPERIENCE [J].
CHEN, DS ;
KUO, GC ;
SUNG, JL ;
LAI, MY ;
SHEU, JC ;
CHEN, PJ ;
YANG, PM ;
HSU, HM ;
CHANG, MH ;
CHEN, CJ ;
HAHN, LC ;
CHOO, QL ;
WANG, TH ;
HOUGHTON, M .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (04) :817-822
[6]   M6P/IGF2R GENE IS MUTATED IN HUMAN HEPATOCELLULAR CARCINOMAS WITH LOSS OF HETEROZYGOSITY [J].
DESOUZA, AT ;
HANKINS, GR ;
WASHINGTON, MK ;
ORTON, TC ;
JIRTLE, RL .
NATURE GENETICS, 1995, 11 (04) :447-449
[7]  
DESOUZA AT, 1995, ONCOGENE, V10, P1725
[8]  
FUJIMOTO Y, 1994, CANCER RES, V54, P281
[9]   A 3-MB PHYSICAL MAP OF THE CHROMOSOME REGION 8P21.3-P22, INCLUDING A 600-KB REGION COMMONLY DELETED IN HUMAN HEPATOCELLULAR-CARCINOMA, COLORECTAL-CANCER, AND NONSMALL CELL LUNG-CANCER [J].
FUJIWARA, Y ;
OHATA, H ;
EMI, M ;
OKUI, K ;
KOYAMA, K ;
TSUCHIYA, E ;
NAKAJIMA, T ;
MONDEN, M ;
MORI, T ;
KURIMASA, A ;
OSHIMURA, M ;
NAKAMURA, Y .
GENES CHROMOSOMES & CANCER, 1994, 10 (01) :7-14
[10]  
FUJIWARA Y, 1995, ONCOGENE, V10, P891